Literature DB >> 2751180

Acute postoperative confusion and hallucinations in Parkinson disease.

W E Golden1, R C Lavender, W S Metzer.   

Abstract

STUDY
OBJECTIVE: To determine whether patients with Parkinson disease are at an increased risk for postoperative confusion.
DESIGN: Retrospective chart review of patients with Parkinson disease who remained in the hospital at least 48 hours after their surgery. Current data were compared with published historical controls.
SETTING: Recent medical records of a university-affiliated hospital, Veterans Administration hospital, and community hospital. PATIENTS: Available charts of patients with Parkinson disease who had had surgery in the last 2 years. Patients were excluded if they were disoriented at admission or had serious metabolic disturbances.
MEASUREMENTS AND MAIN RESULTS: Fifteen of twenty-five postoperative patients with Parkinson disease (60%; CI, 39% to 78%) suffered significant acute confusion, and 9 of these patients had documented hallucinations. Neuropsychiatric changes were frequently delayed after surgery. The acute confusional state lasted an average 2.5 days; several patients, however, were discharged before resolution. These disturbances did not appear to be related to type of anti-parkinsonian medication or anesthetic.
CONCLUSION: In comparison with historical controls, the relative risk of patients with Parkinson disease having an acute postoperative confusional state is between 2.8 and 8.1. These patients may need environmental supports during the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751180     DOI: 10.7326/0003-4819-111-3-218

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

Review 1.  Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.

Authors:  E S Molho; S A Factor
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  Review of delirium in patients with Parkinson's disease.

Authors:  Emma R L C Vardy; Andrew Teodorczuk; Alison J Yarnall
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 3.  [Parkinson's disease. Perioperative management and anesthesia].

Authors:  U Wüllner; J Standop; O Kaut; V Coenen; A Kalenka; F Wappler
Journal:  Anaesthesist       Date:  2012-02       Impact factor: 1.041

4.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 5.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

6.  Olfactory dysfunction is related to postoperative delirium in Parkinson's disease.

Authors:  Min Seung Kim; Jung Han Yoon; Hyun Jae Kim; Seok Woo Yong; Ji Man Hong
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

7.  Inpatient management of Parkinson disease: current challenges and future directions.

Authors:  Odinachi Oguh; Aleksandar Videnovic
Journal:  Neurohospitalist       Date:  2012-01

Review 8.  Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.

Authors:  Deborah A Burton; Grainne Nicholson; George M Hall
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Parkinson's disease and anaesthesia.

Authors:  Safiya I Shaikh; Himanshu Verma
Journal:  Indian J Anaesth       Date:  2011-05

Review 10.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.